Process & Manufacture

We currently operate a commercial-scale manufacturing facility equipped with two 3,500L stainless steel bioreactors, three 500L single-use bioreactors, one 200L ADC drug coupling reactor and various filling lines accommodating products with different formulations. In addition, we are building up additional production lines which, when ready by the end of 2020, will increase production capacity to over 30,000L. We operate a comprehensive quality management system, including the GxP systems from GLP, GCP to cGMP, which enables us to design and conduct global trials and produce drugs for sale in compliance with requirements applicable to and enforced by global competent authorities (including the NMPA, FDA and EMA).